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Abstract
Purine enzyme activities are usually assayed by radiochemical procedures and often TLC is part of the separation 
method. In screening patients with rheumatic diseases, these procedures have shown disadvantages like a relatively 
large coefficient of variation (C.V.) and time-instability. We describe a non-radiochemical reversed-phase HPLC 
micro-method with UV detection for measurement of activities of purine S'-nuclcotidase (5'NT; EC 3.1.3.5), 
purine nucleoside phosphorylase (PNP; EC 2.4.2.1) and hypoxanthine guanine phosphoribosyltransferase 
(HGPRT; EC 2.4.2.8) in human peripheral blood mononuclear cells (PBMC). The HPLC procedure is compared 
with the radiochemical TLC procedure by testing both with a 5'NT and a PNP assay. Reproducibility is tested with
14 healthy controls in each procedure. Short-term and long-term time-stability is tested by comparing enzyme 
activities measured immediately after preparation of the PBMC (week 0) with those found after freezing and 
storage at “ 20°C for a maximum of 10 weeks. The HPLC procedure is preferable to the radiochemical TLC 
procedure because it shows significantly better reproducibility and better time-stability and in addition is 
non-radiochemical and less time-consuming.
1. Introduction
Purine enzymes play an important role in 
physiological as well as in pathological condi­
tions. Several immunodeficiencies are related to 
abnormalities of purine enzyme activities [1-7]. 
Impairment of purine enzyme activities is also
* Corresponding author.
found in autoimmune diseases like autoimmune 
haemolytic anaemia [8,9], systemic lupus erythe­
matosus [10] and rheumatoid arthritis (RA) [11]. 
Recently new data were reported concerning 
purine enzyme levels in RA patients treated with 
azathioprine (AZA) [12].
AZA is an immunosuppressive and cytotoxic 
agent which, after conversion to 6-mercap- 
topurine, is metabolized by purine enzymes. It is
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used in the treatment of a number of autoim­
mune diseases and malignancies and to prevent 
allograft rejection in organ transplant recipients. 
The outcome of AZA treatment may be strongly 
influenced by deficiencies of purine enzymes: 
HGPRT deficiency causes resistance to AZA  
treatment [13] and both thiopurine methyltran- 
sferase deficiency and low levels of 5'NT result 
in increased susceptibility to severe bone marrow 
depression during AZA treatment [14-17].
Purine enzyme activities are often measured 
by radiochemical procedures in combination with 
TLC separation. During a recent screening of 
purine metabolism in patients with RA, we 
found some distinct disadvantages of these pro­
cedures. Firstly, time-stability of enzyme ac­
tivities of the freeze-dried PBMC stored at 
—20°C was not as expected. Secondly, the C.V. 
was relatively large. Thirdly, regarding environ­
mental protection, radiation hygienics and gener­
al applicability, radiochemical assays are out of 
favour nowadays, and finally, these procedures 
are rather time-consuming.
According to a Medline literature search start­
ing from 1982 there are no previous reports 
comparing a radiochemical TLC procedure with 
a non-radiochemical HPLC procedure to mea­
sure activities of the purine enzymes 5'NT and 
PNP, nor reports of HPLC procedures to mea­
sure purine enzyme activities of 5'NT, PNP or 
HGPRT in human PBMC.
In this paper we present a new non-radio­
chemical reversed-phase HPLC micro-method 
which obviates the above-mentioned disadvan­
tages. Reproducibility and time-stability were 
tested with PNP and 5'NT assays using both 
procedures. Time-stability of the HPLC proce­
dure was also tested with an HGPRT assay. 
Tests were carried out with blood samples from 
healthy volunteers.
2. Experimental
2.1. Design o f  the studies
To determine reproducibility each procedure 
was tested with PBMC of 14 different healthy
volunteers. The C.V. was considered for each 
person. Mean age was 51.1 years (range: 43-64) 
in the radiochemical TLC group and 44.3 years 
(28-64) in the HPLC group.
Time-stability was tested with PBMC of 5 and 
3 healthy persons respectively for the radio­
chemical TLC procedure and the HPLC pro­
cedure. The mononuclear cells were isolated 
only once, prepared according to each procedure 
and kept in stock in a number of Eppendorf 
tubes (one tube for each single measurement). 
For the radiochemical TLC procedure enzyme 
activity measurements of PNP and 5'NT were 
done the day after isolation of the PBMC (week 
0) and at weeks 1, 2, 3, 6 and 8. The testing of 
the PNP, 5'NT and HGPRT stability by the 
HPLC procedure was done at weeks 0, 1, 2, 8
and 10.
All enzyme assays were carried out in quad­
ruplicate,
2.2. Isolation o f  mononuclear cells from  
peripheral blood
A 10-ml volume of venous blood was defibri- 
nated (on glass beads) as soon as it was obtained 
and immediately processed for further analysis. 
An equal volume of 0.9% (w/v) NaCl (NPBI) 
was added and 8 ml of this suspension was 
carefully layered on top of a density gradient, 
containing 4 ml Ficoll-Isopaque (density 1.077 
g/ml, Nycomed), Centrifugation (Sorvall RC3, 
DuPont Company, Newtown, CT, USA) was 
carried out at room temperature for 20 min at 
1000 g . PBMC were collected from the interface, 
washed with approximately the same volume of 
0.9% NaCl and centrifuged (Hettich Universal 
30 RF, Hettich Zentrifugen, Tuttlingen, Ger­
many) at 20°C for 5 min at 825 g. The con­
taminating erythrocytes were eliminated by re- 
suspending the cell pellet in a 10-ml erythrocyte 
shock solution consisting of 170 mM Tris 
(Merck) and 155 mM NH4C1 (Merck) (1:9, v/v) 
(pH 7.2-7.4). The suspension was incubated for
15 min in a water-bath at 37°C (Julabo SW-20C, 
Julabo Labortechnik, Seelbach, Germany) and 
centrifuged again at 20°C for 5 min at 825 g. 
After this, the cell pellet was resuspended and
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washed twice in approximately 15 ml of 0.9% 
NaCl and centrifuged after each washing step at 
20°C for 5 min at 825 g. Then the pellet was 
resuspended in 1.25 ml of a solution of 0.9% 
NaCl containing 4% bovine serum albumin (Or­
ganon Teknika, Boxtel, Netherlands) and tem­
porarily stored on ice. Numbers of white blood 
cells were determined by a Coulter Counter 
(Model S5, Coulter Electronics, Luton, UK). 
Mononuclear cell viability, monitored by staining 
with trypan blue, was 94,8 ± 2 .9  (% mean ±  
S.D.), Finally, for each enzyme assay an exact 
number of mononuclear cells, corrected for 
viability, was collected in Eppendorf tubes.
The PNP assay requires 1500 cells for the 
HPLC procedure and 500 cells for the radio­
chemical TLC procedure, the 5'NT assay 18 000 
and 6000 cells respectively and the HGPRT 
assay 15 000 cells for the HPLC procedure.
The cells were frozen at ~70°C and lyophilized 
overnight (Lyovac GT2, Leybold, Köln, Ger­
many). For the radiochemical TLC procedure 
the pretreated cells were stored at -20°C until 
the enzyme assay was carried out. For the HPLC 
procedure, the enzyme assays were performed 
the next day and the supernatants were stored at 
-20°C  until the HPLC separation.
2 3 .  The radiochemical TLC procedure
The enzyme assays, the TLC separation meth­
ods and the calculation of specific enzyme ac­
tivities were carried out essentially according to 
procedures published previously [18].
2.4. The non-radiochemical H PLC procedure 
Enzyme assays
Purine-5'-nucleotidase.
5'NT activity was determined from degrada­
tion of adenosine monophosphate (AMP) to 
adenosine:
5 'N T
AM P--------> adenosine + P¡ ( + inosine
+ hypoxanthine) (1)
A reaction mixture with a pH of 8.5 was used,
consisting of 8 nm ol/10 AMP (Sigma), 225 
niAi Tris (Merck) + 90 mM  MgCl2 (Merck) +  
1.875 mAi ß -glycerolphosphate (Sigma) and 10% 
Triton X-100 (Sigma) (10:20:1, v/v). A  10-/xi 
volume of the reaction mixture was added to the 
lyophilized PBMC. After 3 h of incubation at 
37°C, the reaction was stopped by addition of 10 
/xl of 0.8 M ice-cold perchloric acid (PCA) 
(Merck). The deproteinized incubation mixture 
was centrifuged at 4°C and 17 000 g for 4 min. 
After centrifugation, 15 ¡j-\ of the supernatant 
was neutralized with 35 ju.1 of 0.2 M K2H P 0 4 
(Merck). The neutralized mixture was cen­
trifuged again and the supernatant was stored at 
-20°C.
Purine nucleoside phosphorylase.
PNP activity was determined from the conver­
sion of hypoxanthine to inosine:
PNP
Hypoxanthine + R-l-P--------> inosine + P¡ (2)
The reaction mixture had a pH of 7.0 and 
consisted of 4 nmol/10 /¿I hypoxanthine (Sigma), 
5 mM  ribose-l-phosphate (R-l-P) (Sigma), 0.5 
M Tris+ 10 mAÍ EDTA (Siegfried S.A.) and 
10% Triton X-100 (10:10:10:1, v/v). Of this 
mixture 20 /xl were added to the lyophilized 
PBMC. The reaction was allowed to proceed for
1 h at 37°C. The incubation mixture was de­
proteinized, neutralized and stored according to 
the method used for the purine 5'-nucleotidase 
assay.
Hypoxanthine-guanine phosphoribosyltransfer- 
ase.
HGPRT activity was determined from the 
conversion of hypoxanthine to inosine mono­
phosphate (IMP):
H G P R T
Hypoxanthine + PRPP--------------> IMP + inosine
(3)
A reaction mixture with a pH of 7.4 was used, 
consisting of 4 nmol/10 /xl hypoxanthine 
(Sigma), 8 mAi phosphoribosyl pyrophosphate
(PRPP) (Sigma), 0.5 M Tris+ 0,05 M  MgCl2 
and 10% Triton X-100 (10:10:10:1, v/v). Twenty 
microliters of this mixture were added to the
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lyophilized PBMC. The reaction was allowed to 
proceed for 1.5 h at 37°C. The incubation mix­
ture was deproteinized, neutralized and stored 
according to the method used for the purine 
5'-nucleotidase assay.
H PLC separation method 
An automated HPLC system (LKB, LKB- 
Produkter, Bromma, Sweden) was used consist­
ing of an autosampler (20-/¿l sample loop) (Wa­
ters 717 Autosampler, Millipore Corporation, 
Marlborough, MA, USA), a Supelcosil LC-18-S 
HPLC column (2 5 0 x 4 .6  mm I.D.; particle size 
5 jxm) (Supelco, Bellefonte, PA, USA), a 2150 
HPLC pump (LKB), a continuous mobile-phase 
degasser (LKB 2156 solvent conditioner) and a 
UV detector with wavelength set at 254 nm 
(Applied Biosystems 785 A  programable absor­
bance detector, Applied Biosystems, Foster 
City, USA). Automatic data capture and pro­
cessing were performed by Millenium software 
(Millipore-Waters, USA). The operating pres­
sure was 90 bar and the flow-rate was 1.25 ml/ 
min. A two-buffer system gradient, buffer A  
[0.025 M  KH2P 0 4 (Merck)] and B [25% metha­
nol (Lab-Scan)-75% 0.05 M  KH2P 0 4), was
used for separation (Fig. 1). The method previ­
ously published [19] was modified slightly.
The incubation mixture stored at -20°C was 
thawed and centrifuged at 20°C for 4 min at 
17 000 g. Twenty microliters of the supernatant 
were injected onto the HPLC system.
Control preparations consisted of two blanks, 
the reaction mixture (A) and a combination of 
reaction mixture plus isolated enzyme without 
substrate (B), and three standard solutions. For 
each type of enzyme assay a specific own blank 
A was analyzed. A  blank B was analyzed with 
the HPLC procedure for each enzyme assay per 
person. The three standard solutions were mea­
sured per ten samples. The standard solutions 
contained all six purine nucleotides and nu­
cleosides, each of them in three concentrations.
Calculation o f  specific enzyme activity
For each substrate and each product a stan­
dard curve of the peak area against the con­
centration was made. After separation, the con­
centration of the products could be determined 
from their area under the curve value. The 
specific enzyme activity was calculated and ex­
pressed in nmol/106 viable cells/h.
Buffer A a-- Buffer B
0.023 M K H .F O , Î 5*  C H jO H  + 7J *  0.05 M  K H aP 0 4
Fig. L Gradual change of proportions of the two-buffer system during HPLC separation.
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D
Fig. 2, Chromatograms of (A) a standard mixture of nucleosides and mononucleotides, each at a concentration of 10 fiM; (B) 
PNP purine enzyme assay; (C) 5'NT purine enzyme assay and (D ) HGPRT assay. Peaks: 1 = IMP, 2 =  hypoxanthine, 3 -  AMP, 
4 -  adenine, 5 =  inosine, 6 =  adenosine. Chromatography was performed under the conditions described in the text.
2.5. Statistics
To analyze the reproducibility of both the 
radiochemical TLC and the HPLC procedure, 
the C.V. for the PNP assay and the 5'NT assay 
was calculated from the data-set of each control 
subject. The differences between the procedures, 
regarding the mean C.V., were examined by 
using the non-parametric two-sided Wilcoxon 
rank-sum test.
Differences in time-stability were analyzed on 
the basis of a fixed two-way analysis of variance 
(ANOVA) model with fixed patient effects and a 
mixed two-way ANOVA model with random 
patient effects. Additionally pairwise differences 
between times were analyzed further according 
to the multiple comparison method of Scheffé 
[20].
The statistics were processed by SAS com­
puter software (SAS Institute, Cary, NC, USA) 
and by a SAS macro. Testing results were 
considered significant if 0.05.
3. Results
Examples of HPLC profiles of a standard 
mixture of nucleosides and mononucleotides and 
of the substrates and products from the enzyme
assays are shown in Fig. 2. Only negligible 
amounts of product (inosine in the PNP assay, 
adenosine in the 5'NT assay and IMP in the 
HGPRT assay) were present in the chromato­
grams of the mononuclear cell suspensions incu­
bated without substrate (data not shown).
Under the conditions mentioned before, the 
enzyme assays of the HPLC procedure were 
tested for linearity between product formation 
(enzyme activity) and number of cells used for 
the assay. Per enzyme each data point was 
assayed in triplicate. The results are shown in 
Fig. 3.
Experiments by HPLC with standard nu­
cleotide and nucleoside solutions of IMP, AMP, 
inosine, adenosine and hypoxanthine, each in 
three known concentrations, showed a mean 
recovery ± S.D. of 103.7 ±7.2,  93.7 ± 3.6, 
94.6 ±7.2,  94.3 ±6.1 and 92.8 ±5.9%, respec­
tively.
Analysis of the reproducibility of PNP activity 
and 5'NT activity measured by both methods 
was carried out as described above. All pro­
cedures were performed within the first two 
weeks after blood sampling. The results are 
given in Table 1. In both enzyme assays the C,V. 
of the HPLC procedure was significantly lower 
(p =  0.002).
Time-stability was examined by measuring the
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Fig, 3. Linearity between product formation and the number 
of cells used in the 5'NT (A), PNP (B) and HGPRT (C) 
assays (HPLC procedure).
enzyme activity at certain time intervals of either 
a sample of the pretreated and stored PBMC 
(radiochemical TLC procedure) or a sample of 
the stored supernatant of the deproteinized incu­
bation mixture (HPLC procedure).
The 5'NT assay measured by the radiochemi­
cal TLC procedure (Fig. 4) is not stable in time. 
According to a fixed two-way ANOVA, averaged 
over the 5 persons, not all time means were 
equal (p  <  0.001). This is caused mainly by a 
significant decrease between week 0 and the 
subsequent weeks. During the following weeks 
there is a decreasing trend in averaged 5'NT 
enzyme activities. Examining the data on the 
basis of a two-way mixed ANOVA model with 
random patient effects, followed by a multiple 
comparison procedure of Scheffé (data not 
shown), the same conclusions could be drawn.
For PNP assayed by the radiochemical TLC 
procedure, the hypothesis of equal time means, 
averaged over the 5 persons, also has to be 
rejected ( p <  0.001). A nearly significant de­
crease was found between week 0 and weeks 1, 
3, 6 and 8 (Fig. 4). However, at week 2, the 
enzyme activity is again at the level measured 
before freezing the PBMC. Under the mixed 
two-way ANOVA model (data not shown) the 
differences are somewhat less distinct but still 
point in the same direction.
As regards the 5'NT assay tested by the HPLC 
procedure, the hypothesis of equal time means, 
averaged over 3 persons, has to be rejected 
( p <  0.001) too. No average differences were 
found between weeks 1, 2, 8 and 10 (Fig, 4), but 
enzyme activity in week 0 is significantly higher 
than during the following weeks. The mixed 
two-way ANOVA model with random patient 
effects, followed by a multiple comparison pro­
cedure of Scheffé (data not shown) gives the 
same result and also points to an effect of 
freezing.
The PNP assay measured by the HPLC pro­
cedure is very stable. On average all weeks have 
about the same enzyme activity (p  >  0.10) (Fig.
4).
Concerning the HGPRT assay, averaged over 
the 3 persons, the time means show no equality 
( p <  0.001). However, only at week 8 a sig-
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Table 1
Coefficients of variation of the radiochemical TLC procedure and the HPLC procedure with the PNP and 5'NT enzyme assays
PNP assay 5'NT assay
TLC HPLC TLC HPLC
(n = 14) (in = 14) (n = 14) (n = 14)
Mean C.V. 12.3 6.6 11.2 5.3
S.E.M. 1.4 0.8 1.5 0.9
Percentiles
100% 27.8 14.4 20.3 13.5
50% 11.7 6.0 8.7 4.2
0% 5.1 3.2 2.9 2.0
p-Value* 0.002 0.002
S.E.M.: standard error of the mean C.V.
* Wilcoxon 2-sample test.
nificantly higher mean is found compared with 
the other times (p  ^  0.05) (Fig. 4). The two-way 
mixed ANOVA model showed no differences 
among all the weeks, indicating that the impair­
ment at week 8 is only a minor effect, probably 
not important in studies testing larger groups.
Finally it is noted that for 5'NT and PNP 
assayed by the radiochemical TLC procedure 
and for HGPRT assayed by the HPLC pro­
cedure, the different persons do not show paral­
lel time profiles (interaction tests of the fixed 
two-way ANOVA yielding p = 0.001, p = 0.02 
and p = 0.02 respectively).
4. Discussion
Screening large numbers of patients for their 
purine enzyme activities often causes difficulties 
in planning and questions about feasibility 
because the laboratory procedures are rather 
complicated and time-consuming. These prob­
lems might be overcome if the laboratory pro­
cedure could be interrupted and the patient 
material temporarily stored without effect on the 
enzyme activities measured.
In this way the time stability of the radio­
chemical TLC procedure was tested when it was 
interrupted after isolation, purification, division 
and lyophilization of the PBMC. The results 
were disappointing, because of a gradual de­
crease of 5'NT enzyme activity. Possibly this was 
due to decrease of ecto-5'-nucleotidase activity. 
The localization on the outside of the cell mem­
brane could make this enzyme more sensitive to 
manipulation of the cells than cytoplasmatic 
enzymes. It is obvious that freezing and storing 
at -20°C of prepared mononuclear cells is not 
adequate to preserve 5'NT purine enzyme activi­
ty for a longer period of time. Therefore in our 
study design this radiochemical TLC procedure 
is not acceptable.
The PNP assay in the radiochemical TLC 
procedure shows a more stable enzyme activity 
during the 8 weeks with two exceptions. The 
higher enzyme activity at week 0 indicates a 
possible effect of freezing. No adequate explana­
tion can be given of the significantly higher 
activity in week 2. It is very unlikely that enzyme 
activities return to pre-freezing levels. Although 
activity of week 2 seems to be significantly 
higher, it still falls within the range of the 
standard deviations, so these values may be 
coincidental and part of the normal fluctuations 
of this procedure.
The TLC procedure itself may also play an 
important role in the moderate results. The 
separation between substrate and products is not 
always very sharp and may cause minor errors 
when the several zones have to be cut out for 
fluid scintillation counting. By doing so another 
source of inaccuracy of the results is the crum-
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bling away of small fragments of the thin layer 
from the cellulose carrier. Several sprays used to 
prevent crumbling of the thin layer gave no 
marked improvement of the results.
The above-mentioned difficulties with the 
radiochemical TLC procedure led to develop­
ment of non-radiochemical HPLC procedures 
with UV detection to measure the activities of 
the purine enzymes 5'NT, PNP and HGPRT.
Apart from the separation itself the three main 
differences between the radiochemical TLC and 
the HPLC procedure are, firstly, the larger 
number of cells used in the HPLC procedure 
while it still remains a micro-method; secondly, 
after lyophilization of the PBMC essential steps 
(storage, incubation and separation) have a dif­
ferent sequence in the HPLC procedure; and, 
thirdly, the incubation is terminated by protein 
dénaturation instead of cooling on ice.
The enzymatic conditions of 5'NT, PNP and 
HGPRT in the HPLC procedure are largely 
based on those of the radiochemical TLC pro­
cedure, Each enzyme assay displays a good 
linearity between enzyme activity and a wide 
range of cell numbers. Results of recovery ex­
periments were good as well, and a sharp sepa­
ration of mononucleotides and nucleosides was 
achieved in a total run-time of 25 min.
The reproducibility of the HPLC procedure is 
significantly better than that of the radiochemical 
TLC procedure, for both the PNP assay and 
5'NT assay. Smaller differences in purine en­
zyme activities will be significant sooner in this 
HPLC procedure and with respect to our studies 
of purine enzyme activities in patients with 
rheumatic diseases [12,17], this is an important 
advantage.
Time-stability of the HPLC procedure was 
tested in short-term and long-term follow-up. 
The test with the 5'NT assay shows a clear effect 
between week 0 and the other weeks, indicating 
that freezing at -20°C of the supernatant has 
still a decreasing effect on 5'NT activity mea­
sured. Because this procedure rules out a freez­
ing and storing effect on the enzyme itself the 
cause has to be located on the level of substrate 
(AMP) and/or product [adenosine, (inosine and 
hypoxanthine)]. Apart from the freezing and
storing effect on the enzyme itself this hitherto 
unnoticed influence on substrate and/or product 
may also play an additional role in the decreas­
ing 5'NT activity assayed by the radiochemical 
TLC procedure.
Interestingly, the PNP assay measured by the 
HPLC procedure has a very good time-stability, 
in the short as well as in the long term.
HPLC time-stability tested for the HGPRT 
assay is good, with an unexpected exception in 
week 8. This is probably merely a coincidental 
error and according to the statistical tests not 
important in larger studies.
In conclusion we can say that the non-radio- 
chemical HPLC procedure presented has a far 
better separation capacity for the nucleosides 
and mononucleotides tested than the radio­
chemical TLC procedure. Measurements of ac­
tivities of the purine enzymes 5'NT and PNP by 
the HPLC procedure are highly reproducible and 
the time-stability of the HPLC procedure is also 
better. To guarantee time-stability in the HPLC 
procedure, 5'NT measurements should be car­
ried out after freezing and storing of the pre­
pared sample, whereas these factors have no 
influence on the measurement of PNP and 
HGPRT activity. Since the HPLC procedure is 
non-radiochemical, it complies better with cur­
rent environmental protection policies and 
makes it applicable in common clinical laborator­
ies. Finally this procedure is less time-consuming 
and more practical when larger numbers of 
persons have to be screened.
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